# The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

> **NCT00001075** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 55 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Lamivudine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00001075
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 55 (—)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001075, "The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT00001075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*